Monte Rosa Therapeutics to Participate in Four Investor Conferences
Bitget2026/11/02 12:05- Monte Rosa Therapeutics management will participate in fireside chats at four investor conferences.
- Guggenheim's 3rd Annual Healthcare Innovation Conference in Boston: November 9, 2026, at 8:00 a.m. ET.
- UBS Global Biopharma Conference 2026 in London: November 16, 2026, at 12:00 p.m. GMT.
- Jefferies Global Healthcare Conference in London: November 17, 2026, at 10:00 a.m. GMT.
- Piper Sandler 38th Annual Healthcare Conference in New York: December 1, 2026, at 3:30 p.m. ET.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AppLovin (APP.US) delivers "textbook-level" performance: Q3 revenue surges 55%, net profit margin of 66% tops the advertising industry! $1.4 billion buyback in a single quarter
AppLovin (APP.US) released its financial results for the third quarter of 2026 (ending September 30) after the US stock market closed on Wednesday. The advertising technology company once again delivered a "textbook-level" performance: revenue, net profit, and adjusted EBITDA all reached record highs for a single quarter, with profitability indicators far ahead of major advertising platforms.
BUZZ - Edwards Lifesciences shares rise after raising 2026 profit outlook
BUZZ-AppLovin shares surge due to profit growth in the third quarter